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INTRODUCTION
In spite of progressions in treatment, skin cancer is one of the most common human cancers with > 1 million new cases diagnosed each year, accounting for about 40% of all new cancer cases in the USA (statistic from American Cancer society (ACS, http://www.cancer.org)). Solar ultraviolet (UV) radiation has been blamed as a primary cause of skin cancer, UVB irradiation in particular. 1) Experimentally, UV irradiation acts as both tumor initiator and tumor promoter in animal models.
2) Even though the mechanism for the tumor-promoting potential of UV is not well explained, UVinitiated signal transduction pathways are believed to be responsible for tumor promotion effects. It has been reported that a large number of cellular changes, including activation of transcription factors and protein kinases are accelerated by an exposure of UV irradiation including short (UVC, 200-280 nm), long (UVA, 320-400 nm), and mid (UVB, 280-320 nm) wavelengths. 3) Flavonoids are structurally heterogeneous, polyphenolic compounds present in high concentrations in fruits, vegetables, and other plant-derived foods, such as tea and other beverages, and are commonly fed in the human diet. 4) Flavonoids have numerous physiological health benefits, covering protection from cardiovascular disease and cancer. Most of these health-beneficial effects are thought to derive from effective anti-oxidant and free radical scavenging properties, as well as their ability to regulate many cellular enzymatic functions. 5) In fact, many flavonoids act directly as antioxidants, compensating the toxic reactive oxygen species (ROS) by donation of hydrogen ions, or modulation of cell-signaling pathways. 6) In particular, their anti-oxidant activity has drawn enough attention as a possible preventive dietary supplement against many serious diseases, such as cancer, cardiovascular and neurodegenerative disease. Myricetin (Fig. 1A) is a naturally occurring flavonol with hydroxyl substitutions at the 3, 5, 7, 30, 40, and 50 positions, and commonly ingested through our diet in fruits, vegetables, tea, berries and red wine. Interestingly, myricetin has been suggested to inhibit cellular proliferation and to induce apoptosis in tumor cells. 7, 8) Acquired data have indicated the biological activities of myricetin, such as anti-oxidant, -inflammatory, -carcinogen, -viral, and apoptosis induction in HL-60 human pro-myeloleukemic cells and protection against tumorigenicity in SENCAR mice. 7, 9) Recent investigations revealed that EGF-induced cell transformation was inhibited by myricetin through suppression of activator protein-1 (AP-1) and activation of phosphatidylinositol 3-kinase (PI3K). 10) Notably, molecular and biochemical analyses indicate that myricetin can interact directly with cellular signaling factors, such as, MAPK/ERK kinase 1 (MEK1) with ATP-noncompetitive manner, to inhibit downstream signaling and eventually cell transformation. 11) Other studies have reported that myricetin directly bound to the ATP-binding site of Akt/PKB, JAK1, Fyn, and MKK4. [12] [13] [14] [15] These accumulated data suggest that myricetin may target multiple molecules to exert its chemopreventive effects.
Apoptosis is an active suicidal mechanism that is applied to eliminate unwanted or potentially deleterious cells under a variety of physiological and pathological circumstances, in multi-cellular organisms. It is generally accepted that induction of apoptosis following UV radiation is an important defensive mechanism to ensure the removal of irreversibly damaged and potentially carcinogenic cells. UVB-induced genomic DNA damage has been suggested to be a crucial event occurring commencement of the apoptotic program. Furthermore, formation of ROS following UV radiation appears to be an additional factor in triggering the apoptotic machinery. 16) Because keratinocytes that are too seriously damaged for DNA repair undergo apoptosis, misregulation of UVB-induced apoptotic process may have a cardinal effect on induction of skin cancer. Generally, the initiation of apoptosis is controlled by regulation of the balance between death and survival signals recognized by a cell. 17) Identified characterization of survival signaling pathways stimulated by various growth factors has revealed that PI3K is involved in protecting cells from allowing apoptotic cell death. 18) A well-known target of PI3K is the serine/threonine kinase, Akt, also designated as protein kinase B (PKB). Ectopic expression of Akt, especially constitutively active Akt, induces cell survival and malignant transformation, whereas inhibition of Akt activity induces apoptosis in a wide scope of mammalian cells. 19) Fully activated Akt, successively, functions to promote cell survival by phosphorylating several downstream targets including the Bcl-2 family member Bad, IκB kinase, caspase family member caspase-9, and forkhead family transcription factor FKHRL1. [20] [21] [22] [23] [24] [25] [26] Bad is a member of the BH3-only proteins, a subgroup of Bcl-2 apoptotic regulators which contain only one of the bcl-2-homologous regions (BH3). In response to apoptotic stimuli, BH3-only proteins are translocated to the mitochondria from other cellular compartments, leading to cell death by apoptosis. 25, 27) Bad is capable of forming heterodimers with the anti-apoptotic partner proteins, Bcl-xL and Bcl-2, and counteracts their anti-apoptotic activity resulting in mitochondrial dysfunction. 28, 29) Subsequently, mitochondrial apoptogenic proteins, including cytochrome c, the second mitochondria derived activator of caspase (Smac), and apoptosis-inducing factor (AIF), are released into the cytosol, leading to caspase activation and eventual cell death processes. [30] [31] [32] Accordingly, the Akt cascade, via its control of Bad activity, has appeared as an important regulatory mechanism upstream of mitochondria in the maintenance of cell viability. 20) In the present study, we explored the roles of myricetin in regulations of Akt and Bad in a low dose UVB-induced mitochondrial dysfunction and cell death in human HaCaT cells. We demonstrated that myricetin induced inactivation of Akt, followed by Bad activation/translocation, mitochondrial dysfunction, release of mitochondrial molecules (cytochrome c, Smac and AIF), and caspase activation, contributing to induction of apoptosis in a low dose UVBirradiated cell.
MATERIALS AND METHODS

Reagents
Myricetin was purchased from Sigma (St. Louis, MO). Cell culture media and fetal bovine serum were acquired from Gibco (Grand Island, NY). Recombinant Akt and GSK-3α/β were acquired from Upsate Biotechnology (Lake Placid, NY). Antibodies against Akt, p (phospho)-Akt (Ser473, Thr308), β-actin, Bad, p-Bad (Ser155, Ser136), 14-3-3β, Bcl-xL, Lamin A/C and AIF were acquired from Santa Cruz Biotechnology (Santa Cruz, CA). Antibodies specific for p-GSK-3α/β (Ser21/9), VDAC1, cytochrome c, Smac, caspase-3, and poly (ADP-ribose) polymerase (PARP) were acquired from Cell Signaling Technology (Beverly, MA). Akt inhibitor X (10-(4'-(N-diethylamino)butyl)-2-chlorophenoxazine), PI3K inhibitor LY294002, and caspase inhibitors (z-LEHD-fmk , z-VAD-fmk) were acquired from Calbiochem (San Diego, CA).
Cell culture and UVB irradiation
The immortalized human keratinocytes cell line, HaCaT, was cultured in Dulbecco's modified Eagle's media (DMEM) supplemented with glutamine (2 mM), penicillin (400 U/ml), streptomycin (50 mg/ml), and 10% FBS at 37°C in a humidified atmosphere containing 5% CO2. 33) For treatment, cells were cultured to 80% confluence and then maintained in culture media without FBS for 6 h. Cells were washed with phosphate-buffered saline (PBS) and then covered with a thin layer of PBS, followed by treatment with UVB (15 mJ/cm 2 ) and myricetin (20 μM). Culture medium was replaced with fresh medium, and cells were further incubated for indicated hours after UVB treatment. Specific inhibitors were added when required 30 min before UVB and/or myricetin treatment. Cells were irradiated using a BLE-8T312 bulb (Spectronics corp. Westbury, NY), which emits most of their energy within a UVB range of 290-320 nm with an emission peak at 312 nm. Strength of UVB irradiation was measured using a phototherapy radiometer (International Light, Newburyport, MA).
Isothermal titration calorimetry (ITC)
Direct interaction between Akt and myricetin was measured using a MicroCal VP-ITC instrument at 25°C following standard procedures. Recombinant Akt was equilibrated with 20 mM Tris buffer (pH 7.5) containing 150 mM NaCl. Protein was added to the calorimetric reaction cell at a concentration of 0.01 mM and titrated with 0.1 mM myricetin or myricetin/ATP mixture in the same buffer. Enzyme and ligand solutions were degassed prior to use. Each titration experiment was performed with 29 injections of 10 μl at 300 -s equilibration intervals. Heat of dilution for an individual ligand was determined by titration of the ligand into the same buffer without protein and used in correction of the protein titration. Data were fit to a single-site binding model by non-linear least-square regression using the Origin software package. The fit of data yields the binding affinity (Kd), enthalpy change (ΔH), entropy change (ΔS), and binding stoichiometry for the titration.
Thiazolyl blue tetrazolium bromide assay (Cell viability assay)
HaCaT cells were seeded and cultured in 24-well plate with or without myricetin for the indicated time period. Media were removed and 0.05% thiazolyl blue tetrazolium bromide solution was added that was followed by incubation at 37°C for 2 hr. Thiazolyl blue tetrazolium bromide solution was then replaced with dimethyl sulfoxide and incubated 10 min. After incubation, the solution was aliquoted into 96-well plate in duplicate and the absorbance was measured.
Immunoblotting and immunoprecipitation
Following the desired treatments, cell lysates were prepared in non-denaturing lysis buffer (10 mM Tris, pH 7.4, 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 1 mM EGTA, 0.3 mM phenylmethylsulfonyl fluoride, 0.2 mM sodium orthovanadate, 0.5% NP-40, 5 U/ml aprotinin) and protein concentration in the lysates was determined using a Bio-Rad protein assay kit (Bio-Rad Laboratories, Hercules, CA). For immunoblot analyses, 40 μg of protein lysates per sample were denatured in 2 × SDS-PAGE sample buffer and subjected to SDS-PAGE on Tris-glycine gels. Separated proteins were transferred to a nitrocellulose membrane followed by blocking with 5% (w/v) non-fat milk powder in TBST (10 mM Tris, 100 mM NaCl, 0.1% Tween 20) for 1 h at room temperature or overnight at 4°C. Membranes were then probed with specific primary antibodies followed by peroxidase-conjugated secondary antibody and visualized using an ECL detection system.
For immunoprecipitation studies, 200 μg of protein was immunoprecipitated overnight with anti-Bad primary antibody and protein A-agarose beads (50 μl, Santa Cruz, CA). Immunoprecipitates thus obtained were washed three times with lysis buffer and samples were boiled in 2 × SDS-PAGE sample buffer for 5 min followed by centrifugation. Result-ing clear supernatants were subjected to SDS-PAGE gel. Separated proteins were electrophoretically transferred to a nitrocellulose membrane followed by blocking with 5% (w/v) non-fat milk powder in TBST for 1 h at room temperature. The membrane was then probed and visualized for the specific target protein as detailed above.
Akt kinase assay
Akt kinase assay was performed using reagents supplied by the manufacturer (Cell Signaling Technology). Briefly, 3 × 10 6 cells were plated and allowed to attach by overnight incubation. Cells were then treated with myricetin, UVB and Akt inhibitor for specified combination and lysed with a solution containing 20 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM β-glycerophosphate, 1 mM Na3VO4, 1 μg/ml leupeptin and 1 mM phenylmethylsulfonyl fluoride. Equal amounts of lysate proteins (200 μg) from control and UVB-, myricetin and/or inhibitor-treated HaCaT cells were incubated overnight at 4°C with agarose-coupled anti-Akt antibody. Immunoprecipitated complexes were washed four times with lysis buffer and twice with kinase buffer (25 mM Tris (pH 7.5), 5 mM β-glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3VO4 and 10 mM MgCl2).
Immunoprecipitates were resuspended in 30 μl of kinase buffer supplemented with 200 μM of ATP and 1 μg of GSK-3α/β fusion protein. After incubation at 30°C for 30 min, the kinase reaction was terminated with the addition of 40 ml of 2 × SDS-PAGE sample buffer. An aliquot (30 μl) was subjected to immunoblotting and probed with anti-phospho-GSK-3α/β(Ser21/9)-antibody.
Cell fractionation
Mitochondrial subfractions were prepared from HaCaT cells according to a previously described protocol. 34 ) Specific treated cells were first collected and washed in PBS buffer and allowed to swell for 30 min on an ice-cold isotonic buffer A (250 mM sucrose, 1 mM EDTA and 10 mM Tris-HCl, pH 7.5, protease inhibitor AEBSF (Roche, Mannheim, Germany)). Cells were then Dounce (B piston, 100 times passage) homogenized on ice in the same buffer. Nuclei were pelleted at 1,000 × g and supernatant centrifuged at 6,000 × g for 15 min at 4°C to pellet mitochondria. To prepare the nuclear protein extracts, cells were harvested and collected by centrifugation. Cells were suspended in buffer B (10 mM HEPES, pH 7.9, 50 mM NaCl, 1 mM DTT, 0.1 mM EDTA, and protease inhibitors) for 20 min on ice. An equal volume of buffer C (buffer A + 0.1% NP-40) was then added and the suspension was allowed to sit for 20 min on ice. Following centrifugation, the supernatant (cytosol fraction) was collected and subjected to centrifugation at 5000 × g for 2 min to remove cellular debris. Nuclear pellet was washed two times with buffer B and resuspended using buffer D (10 mM HEPES, pH 7.9, 400 mM NaCl, 1 mM DTT, 1 mM EDTA, 1 mM EGTA). The nuclear fractions were cleared of debris by centrifugation at 13,000 rpm for 15 min at 4°C.
Determination of mitochondrial membrane potential (MMP, ΔΨ m )
MMP was determined using the lipophilic cationic probe JC-1 (5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide). Relative intensity of red and green fluorescent signals is an indication of whether or not mitochondrial damage has occurred. HaCaT cells with specific treatments were incubated in the dark with JC-1 at a final concentration of 10 μM for 20 min at 37°C. Cells were washed twice in cold PBS, resuspended in a total volume of 500 μl, and analyzed by flow cytometry at the end of the incubation period.
Transient transfection
HaCaT cells were transiently transfected with pCMV6 vector containing constitutively active Akt1 (Myr-Akt1-HA, Upstate Biotechnology) or empty vector using Lipofectamine TM 2000 (Invitrogen, Carlsbad, CA). Briefly, cells were plated at a density of 5 × 10 5 cells/ml and allowed to attach overnight. Cells were transfected with expression constructs either encoding constitutively active Akt or empty vector. Cells were collected and processed for designed assay after 6 hr.
Apoptosis assay
Apoptosis induction in the myricetin-treated HaCaT cell line was assessed by analysis of cytoplasmic histoneassociated DNA fragmentation. Briefly, 4 × 10 5 cells were plated in 96-well plates and allowed to attach by overnight incubation. Cells were then exposed to desired treatment (myricetin and/or UVB). Cytoplasmic histone-associated DNA fragmentation was determined using a kit from Roche Diagnostics GmbH (Mannheim, Germany) according to the manufacturer's instructions.
Statistical analysis
All numeric data are presented as mean ± standard deviation (SD) from at least five independent experiments and analyzed using a one-way analysis of variance on ranked data, followed by a Tukey's honestly significant difference test in Prism 4 (GraphPad Software, San Diego, CA). A p value < 0.05 was considered statistically significant.
RESULTS
Myricetin directly binds Akt with ATP-competitive manner
Given the biological properties of myricetin and recent biochemical analysis of Akt with myricetin, we hypothesized that Akt is a direct target for myricetin in regulation of viability and apoptosis in UV-damaged cells. 12) In order to investigate the direct interaction between myricetin and Akt, isothermal titration calorimetry (ITC) was employed for study of Akt in terms of its differential ligand affinity between the myricetin only and myricetin/ATP complex. 35) Calorimetric data revealed that heat was released when myricetin was associated with Akt, indicating that this interaction had significant enthalpic contributions to binding (Fig. 1B) . ITC showed that myricetin bound Akt with a stoichiometry of 1:1, indicating that the protein concentration was determined with reasonable accuracy and that the protein was properly folded. As shown in Fig. 1B 
Myricetin inhibits Akt kinase activity in UVB-irradiated cells
First, to examine the cytotoxic effect of myricetin on HaCaT, cells were treated with different doses and cell viability was measured using triazolyl blue tetrazolium bromide assay. As shown in Fig. 2A , there were no cytotoxic effects on cells up to 20 μM myricetin treatments itself. In addition, the same concentration of myricetin has been suggested to inhibit cellular transformation. 12) According to these results and biological meaning of this dose, this condition was adopted in following experiments to investigate myricetininduced mechanism in UVB-irradiated cells.
In order to determine whether or not binding of myricetin to Akt influences its activation, we next investigated the effect of myricetin on Akt phosphorylation and kinase activity in UVB-irradiated cells. We determined the effect of myricetin treatment on activating phosphorylations of Akt (Ser473 and Thr308) in UVB-irradiated cells by immunoblotting and results were shown in Fig. 2B . Levels of Ser473 and Thr308 phosphorylated Akt after UVB (15 mJ/cm 2 ) treatment were sufficiently reduced on immediate treatment of HaCaT cells with 20 μM myricetin after UVB treatment. However, myricetin treatment did not alter total Akt protein level. As a positive control, Akt inhibitor X and PI3K inhibitor LY294002 also showed inhibitory effects (lane 5 and 6). Akt kinase assay further demonstrated that myricetin significantly suppressed Akt kinase activity in UVB-irradiated 
Fig. 2. Myricetin inhibits Akt kinase activity in UVB-irradiated cell. (A)
The effect of myricetin on viability on HaCaT cells was measured by triazolyl blue tetrazolium bromide assay. Cells were treated with myricetin up to 50 μM for 6, 12, 18, and 24 hr. The absorbance was measured at 570 nm. All samples were done in double and the data are presented as mean ± S.E.M. (B and C) For treatment, cells were maintained in culture media without FBS for 6 h and then covered with a thin layer of PBS, followed by treatment with UVB (15 mJ/cm 2 ) and myricetin (20 μM). Culture medium was replaced with fresh medium, and cells were further incubated for 4 hours. Specific inhibitors were added when required 30 min before UVB and/or myricetin treatment. (B) Immunoblotting for phospho-Akt (Ser473 and Thr308) using lysates from UVB-irradiated HaCaT cells treated with myricetin. The blots were stripped and reprobed with anti-actin antibody to ensure equal protein loading. (C) Akt kinase activity in lysates from UVB-irradiated HaCaT cells treated with myricetin. Activity of Akt was determined by immunoprecipitation kinase assay. After incubation at 30°C for 30 min, the kinase reaction was subjected to immunoblotting and probed with anti-phospho-GSK-3α/β(Ser21/ 9)-antibody. Immunoblotting for each protein was performed at least three times, with comparable results. cells in vitro, and inhibitor X treatment was used as a positive control (Fig. 2C) .
Myricetin treatment causes Bad activation in UVBirradiated cells
One prominent mechanism by which activated Akt promotes cell survival involves phosphorylation of pro-apoptotic Bcl-2 family member Bad. 20) Phosphorylation of Bad at Ser155 and Ser136 was markedly reduced on treatment of UVB-irradiated cells with 20 μM myricetin (Fig. 3A) .
In its dephosphorylated state, Bad is localized to the outer mitochondrial membrane where it binds to and antagonizes pro-survival Bcl-2 family proteins such as Bcl-xL. 28, 36) Growth factor-mediated phosphorylation of Bad causes its cytoplasmic sequestration due to increased binding with 14-3-3 proteins, which prevents interaction of Bad with proapoptotic Bcl-2 family members. 20, 28, 37) To test whether or not myricetin treatment affected interaction between Bad and 14-3-3 proteins in UVB-irradiated cells, we immunoprecipitated Bad using lysates from myricetin-treated (20 μM, 4 h) cells, and the immunoprecipitated complexes were then subjected to immunoblotting using anti-14-3-3β antibody. As shown in Fig. 3B , complex formation between Bad and 14-3-3β was markedly reduced in myricetin-treated HaCaT cells. The same blot was reprobed with anti-Bad antibody to ensure equal immunoprecipitation from control and myricetin-treated lysates (Fig. 3B) . In addition, Bad-14-3-3 complex dissociation was accompanied by association of Bad and Bcl-xL (Fig. 3B) . These results suggest that Bad dephosphorylation followed by dissociation of Bad from 14-3-3 and subsequent association of Bad and Bcl-xL is involved in the myricetin-induced mitochondrial apoptotic pathway in UVB-irradiated cells.
Myricetin causes mitochondrial localization of Bad/ Bcl-xL complex, mitochondrial dysfunction and release of mitochondrial molecules in UVB-irradiated cells
To explore whether or not myricetin-induced apoptosis in UVB-irradiated cells was mediated through mitochondrial dysfunction, we determined Bad translocation to mitochondria, mitochondrial membrane potential, and release of mitochondrial apoptotic proteins such as cytochrome c, Smac and AIF (Fig. 4) . Because myricetin treatment reduced interaction between Bad and 14-3-3β (Fig. 3) , we first tested the possibility of whether or not myricetin promoted translocation of Bad to the mitochondria in UVB-irradiated cells. Figure 4A showed that translocations of Bad and Bcl-xL, probably as a complex form, into mitochondria were increased by myricetin-treatment in UVB-irradiated cells. Collectively, myricetin-mediated inactivation of Akt was associated with dephosphorylation and mitochondrial translocation of Bad in UVB-irradiated cells.
To investigate mitochondrial dysfunction, we determined the mitochondrial membrane potential with the mitochondriasensitive cationic lipophilic probe JC-1 to assess the mitochondrial membrane potential (ΔΨm). 38) In this assay, the mitochondria of non-apoptotic cells appeared in red following aggregation of the JC-1 reagent, which emits red fluorescence at 590 nm. In contrast, JC-1 dye remained in its monomeric form in the apoptotic or dead cells, thereby emitting relatively more green fluorescence. As shown in Fig.  4B , treatment of UVB-irradiated HaCaT cells with 20 μM myricetin potentiated the loss of mitochondrial membrane potential. As a positive control, Akt inhibitor X showed similar mitochondrial membrane potential.
Several molecules including cytochrome c, Smac, and AIF are known to be released from mitochondria and to induce apoptosis via caspase-dependent and caspase-independent pathways. 32, [39] [40] [41] Cytochrome c and Smac have been reported to induce apoptosis via caspase-dependent pathways. 32) In contrast, the mitochondrial death-executing molecule, AIF, can translocate to the nucleus and induce caspase-independent cell death upon apoptotic stimuli. 31) To establish whether or not myricetin induces cytochrome c or Smac protein release from mitochondria to the cytosol and AIF translocation to the nucleus in UVB-irradiated cells, levels of these proteins in the cytosolic fraction or nuclear fraction were determined. As shown in Fig. 4C , myricetin caused a marked increase in cytosolic levels of cytochrome c, Smac, and AIF in UVBirradiated cells. These findings suggest that myricetin is possibly involved in both caspase-dependent and caspaseindependent cell apoptosis in UVB-irradiated HaCaT cells.
Myricetin-induced Akt inactivation is involved in Bad activation and subsequent apoptosis in UVB-irradiated cells
To further confirm whether or not Akt inactivation by myricetin induces to UVB-irradiated cell apoptosis, HaCaT cells were transiently transfected with constitutively active Akt (CA-Akt). Cells transfected with the empty vector were used as control. Overexpression of CA-Akt in transfected Fig. 4 . Myricetin causes mitochondrial localization of the Bad/Bcl-xL complex, mitochondrial dysfunction and release of mitochondrial molecules in UVB-irradiated cells. Cell treatment conditions were the same as Fig. 1 (C and D) . (A) Immunoblotting with anti-Bad and anti-Bcl-xL antibody using mitochondrial fractions from UVB-irradiated HaCaT cells treated with myricetin. The blots were stripped and reprobed with anti-VDAC1 and anti-actin antibody to ensure equal protein loading and fractional controls. (B) UVB-irradiated HaCaT cells treated with 20 μM myricetin were determined using JC-1. Each column represents mean ± S.E.M. of at least five independent experiments. P < 0.05, compared with the control group or treatment of UVB only. (C) UVB-irradiated HaCaT cells were treated with myricetin and subjected to immunoblotting with antibodies against cytochrome c, Smac, or AIF using the cytosolic or nuclear fraction. The blots were stripped and reprobed with anti-actin, anti-VDAC1 and anti-Lamin A/C antibody to ensure equal protein loading and fractional controls. cells was confirmed by immunoblotting using antibodies against total Akt and phospho-Akt (Ser473) (Fig. 5A) . As compared to vector transfected cells (only endogenous Akt was detected), the higher level of Akt was detected in CAAkt transfected cells. In vector-transfected UVB-irradiated HaCaT cells, myricetin treatment caused a statistically significant increase in cytoplasmic histone-associated DNA fragmentation (a measure of apoptotic cell death) compared with mock-treated control. However, myricetin-induced increase of cytoplasmic histone-associated DNA fragmentation was not observed in HaCaT cells overexpressing CAAkt (Fig. 5B) .
To further confirm caspase-dependence in our model, we determined the effects of z-VAD-fmk (a pan caspase inhibitor) and z-LEHD-fmk (a caspase-9 specific inhibitor) on myricetin-induced cleavage of caspase-3 in UVB-irradiated cells. As can be seen in Fig. 5C . Each column represents mean ± S.E.M. of at least five independent experiments. P < 0.05, compared with treatment of UVB only and vector transfected. (C) Immunoblotting for caspase-3 and PARP using lysates from UVB-irradiated HaCaT cells treated with myricetin and/or caspase inhibitors. HaCaT cells were pretreated for 30 min with 30 μM z-VAD-fmk or z-LEHD-fmk and then exposed to UVB and myricetin. After 6 hours, cell lysates were prepared, and used for immunoblotting using antibodies specific for detection of caspase-3 and cleaved PARP. The blots were stripped and reprobed with anti-actin antibody to ensure equal protein loading. (D) The effect of apoptosis by myricetin on viability was measured by triazolyl blue tetrazolium bromide assay. Cell treatment conditions were the same as experiments shown in Fig. 5C . The absorbance was measured at 570 nm. All samples were done in triplicate and the data are presented as mean ± S.E.M.
procaspase-3 was blocked in the presence of 30 μM pan caspase inhibitor z-VAD-fmk and caspase-9 specific inhibitor z-LEHD-fmk. Myricetin-induced cleavage of PARP, a substrate of activated caspase-3, was significantly blocked in the presence of z-VAD-fmk and z-LEHD-fmk. In addition, the cell viability was measured to relate the biochemical results with cell survival using triazolyl blue tetrazolium bromide assay (Fig. 5D) . Consistent with the cleavages of caspase-3 and PARP (Fig. 5C ), the cell viability was reduced by myricetin treatment (20 μM) in UVB-irradiated HaCaT cells and recovered in the presence of pan caspase inhibitor z-VAD-fmk and caspase-9 specific inhibitor z-LEHD-fmk.
DISCUSSION
Because UVB radiation acts not only by inducing DNA damage and cell mutagenecity, and can also modulate expression of several target genes at dose levels relevant to natural solar exposure, UVB is considered a most cardinal environmental risk factor for skin cancers.
1) UVB irradiation can be classified into 'repairable dose (lower dose)' and 'apoptotic dose (higher dose)' and the repairable threshold dose of UVB is known as about 15 mJ/cm 2 . 42) Whereas a lower dose of UVB can cause tumor initiation, a higher dose motivates irreparable DNA damage, causing apoptosis and eventually cell death. 43) It has been reported that induction of apoptosis is considered to be an essential tumor prevention mechanism at the cellular level, as it completely removes unrepairable DNA damage by cell death. 42) Therefore, misregulation of UV-induced apoptosis confers the high risk of malignancy. Apoptosis, a form of programmed cell death involved in tissue morphogenesis and homeostasis, is characterized by cytoplasmic shrinkage, nuclear condensation and DNA fragmentation. Specific therapeutic strategy designed to improve or decrease susceptibility of individual cell types to apoptosis could establish the foundation for treatment of a variety of human diseases, such as cancer. 44) The present study was performed to investigate possible involvement of myricetin in apoptosis by inhibition of Aktmediated survival in a low dose UVB-irradiated HaCaT cells. The rationale for examining the effect of myricetin on Akt signaling axis in UVB-irradiated cells was based on the following considerations: (i) myricetin directly binds to the Akt ATP-binding site and attenuates downstream signaling to inhibit cell transformation, 45) (ii) Akt modulates the function of numerous proteins involved in regulation of cell survival, cell-cycle progression and cell death, 46) (iii) Akt activation has been observed in spontaneously developing tumors of a transgenic mouse model 47) and (iv) Akt inactivation is implicated in regulation of apoptosis by agents that include the cruciferous vegetable-derived natural cancer chemopreventive agent indole-3-carbinol.
48) The present study reveals that myricetin treatment causes a decrease in activating phosphorylation of Akt (Ser473 and Thr308) in UVB-irradiated HaCaT cells. Ser473 and Thr308 phosphorylation of Akt occurs in response to growth factor stimulus and is necessary for maximal activation of Akt. 46) Myricetinmediated suppression of Akt phosphorylation in UVBirradiated cells is linked to inhibition of the kinase activity of Akt as judged by kinase assay (Fig. 2C) . Relative resistance of HaCaT cells transfected with constitutively active Akt towards myricetin-induced apoptosis compared with vector transfected controls further supports that Akt inactivation contributes to cell death caused by myricetin in UVBirradiated cells (Fig. 5B) . However, further studies are needed to probe into the question of whether or not the association between myricetin-mediated Akt inactivation and cell death is general to broad cell types.
Activated Akt can phosphorylate several apoptosis regulating proteins including pro-apoptotic Bcl-2 family member Bad. 20) Bad promotes cell death by interacting with antiapoptotic Bcl-2 members such as Bcl-xL, which allows mitochondrial dysfunction and causes release of apoptogenic molecules (e.g. cytochrome c) from mitochondria to the cytosol dealing with caspase activation and cell death. [30] [31] [32] Results from the current study indicate that myricetinmediated inactivation of Akt is associated with reduced Ser136 and Ser155 phosphorylation of Bad in UVB-irradiated cells. We also found that myricetin treatment reduced interaction between Bad and 14-3-3β in UVB-irradiated cells as revealed by immunoprecipitation-immunoblotting experiment (Fig. 3) leading to mitochondrial localization of Bad (Fig. 4A) . It has been known that the activated Akt can also phosphorylate apoptosis signal-regulating kinase 1 (Ask-1) at Ser83 resulting in inhibition of Ask-1 activity. 49) Ask-1 acts upstream of JNK and p38 mitogen-activated protein kinase (MAPK). 50) Currently, there is still controversy with regard to the exact role of JNK and p38 in UV-induced apoptosis, with both pro-and anti-apoptotic activity. How myricetin-mediated inactivation of Akt in UVB-irradiated cells is related to the MAPK pathway and regulation of apoptosis is not clear at present and further study is needed. Activation of caspases leads to cleavage and inactivation of key cellular proteins such as PARP. In the present study, we showed that myricetin-induced cleavage of caspase-3 and PARP was significantly prevented on pre-treatment with both pan caspase inhibitor and caspase-9 specific inhibitor (Fig. 5C ). Because myricetin-induced apoptosis is also significantly attenuated in the presence of z-VAD-fmk and z-LEHD-fmk (Fig. 5B) , we postulate involvement of intrinsic caspase cascade in cell death caused by myricetin in UVBirradiated cells. In addition, based on the AIF translocation into nucleus, the possibility of caspase-independent apoptotic pathway by myricetin cannot be ruled out in UVB-irradiated cells. HaCaT cells, which are used in these experiments, are non-malignant when injected into nude mice and are essentially used as normal keratinocytes. 33) HaCaT cells retain mutant p53 alleles, which accounts for their sensitivity to myricetin-induced apoptosis, as stabilization of p53 is essential for up-regulation of DNA damage repair proteins. 51) Therefore, based on our results, myricetin may act in a p53-independent way in affording sensitization against low dose UVB-caused cell proliferation in HaCaT cells. Again, consistent with this report, myricetin-induced apoptosis in HaCaT cells is caspase-dependent. A simplified depiction of our proposed anti-skin cancer mechanism of myricetin in UVB-irradiated cells is shown in Fig. 6 . Efficacy of myricetin may be of significance in deletion of transformed cells that are exposed to sunlight during daily life, especially since the dose that we used in this study falls within the physiological range of UVB exposure. 52) Another important issue in the present study is the fact that myricetin post-treatment was used throughout the study, which totally rules out the possibility of any sunscreen effect of myricetin and suggests that the observed molecular/ signaling effects are associated with the protective effects of myricetin against UVB-caused cell proliferation and tumorigenesis.
In conclusion, the present study demonstrates that myricetin treatment inactivates Akt to block Bad phosphorylation, which leading to reduced interaction between Bad and 14-3-3β, and then mitochondrial translocation of Bad in UVBirradiated cells. Considering the important role of Akt in oncogenesis, the present study suggests that myricetinmediated inactivation of Akt in UVB response may play a role in regulation of UVB-induced carcinogenesis. To the best of our knowledge, the present study is the first report to link modulation of the Akt signaling axis in UVB-induced cell death caused by a naturally occurring polyphenolic compound, myricetin. These findings reveal that a new regulatory mechanism of UVB-induced apoptosis and myricetin may be useful as a potential template for development of better chemopreventive and/or chemotherapeutic agents against skin cancer. Fig. 6 . The simplified depiction of the proposed anti-skin cancer mechanism of myricetin. Treatment of UVBirradiated HaCaT cells with an apoptosis-inducing concentration of myricetin resulted in a decrease in kinase activity of Akt. Myricetin treatment also caused a decrease in phosphorylation of Bad and interaction between Bad and 14-3-3β was reduced markedly in UVB-irradiated cells. Comparably, myricetin treatment promoted mitochondrial translocation of Bad, loss of the mitochondrial membrane potential, release of the mitochondrial apoptotic proteins and eventually caspase activation, contributing to induction of apoptosis in a low dose UVB-irradiated cell.
